Logo image of ALT

ALTIMMUNE INC (ALT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ALT - US02155H2004 - Common Stock

3.86 USD
-0.12 (-3.02%)
Last: 12/26/2025, 8:27:56 PM
3.8401 USD
-0.02 (-0.52%)
After Hours: 12/26/2025, 8:27:56 PM
Fundamental Rating

3

Taking everything into account, ALT scores 3 out of 10 in our fundamental rating. ALT was compared to 530 industry peers in the Biotechnology industry. The financial health of ALT is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ALT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALT had negative earnings in the past year.
In the past year ALT has reported a negative cash flow from operations.
In the past 5 years ALT always reported negative net income.
In the past 5 years ALT always reported negative operating cash flow.
ALT Yearly Net Income VS EBIT VS OCF VS FCFALT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

ALT has a better Return On Assets (-38.41%) than 60.19% of its industry peers.
Looking at the Return On Equity, with a value of -45.21%, ALT is in the better half of the industry, outperforming 68.49% of the companies in the same industry.
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROIC N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ALT Yearly ROA, ROE, ROICALT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALT Yearly Profit, Operating, Gross MarginsALT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K

More info and screens

5

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALT has been increased compared to 1 year ago.
Compared to 5 years ago, ALT has more shares outstanding
ALT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALT Yearly Shares OutstandingALT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALT Yearly Total Debt VS Total AssetsALT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 3.12 indicates that ALT is not in any danger for bankruptcy at the moment.
ALT's Altman-Z score of 3.12 is fine compared to the rest of the industry. ALT outperforms 68.68% of its industry peers.
ALT has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.08, ALT is not doing good in the industry: 62.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 3.12
ROIC/WACCN/A
WACC8.78%
ALT Yearly LT Debt VS Equity VS FCFALT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
ALT has a Current ratio of 17.18. This is amongst the best in the industry. ALT outperforms 93.77% of its industry peers.
A Quick Ratio of 17.18 indicates that ALT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 17.18, ALT belongs to the best of the industry, outperforming 93.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.18
Quick Ratio 17.18
ALT Yearly Current Assets VS Current LiabilitesALT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.15%, which is quite impressive.
The Revenue for ALT has decreased by -61.54% in the past year. This is quite bad
The Revenue for ALT have been decreasing by -67.82% on average. This is quite bad
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%

3.2 Future

The Earnings Per Share is expected to grow by 38.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALT will show a very strong growth in Revenue. The Revenue will grow by 889.71% on average per year.
EPS Next Y26.03%
EPS Next 2Y3.59%
EPS Next 3Y5.36%
EPS Next 5Y38.08%
Revenue Next Year112.6%
Revenue Next 2Y0%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALT Yearly Revenue VS EstimatesALT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 500M 1B 1.5B
ALT Yearly EPS VS EstimatesALT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 -20 -40 -60 -80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALT Price Earnings VS Forward Price EarningsALT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALT Per share dataALT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.59%
EPS Next 3Y5.36%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ALTIMMUNE INC

NASDAQ:ALT (12/26/2025, 8:27:56 PM)

After market: 3.8401 -0.02 (-0.52%)

3.86

-0.12 (-3.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners40.48%
Inst Owner Change6.67%
Ins Owners0.62%
Ins Owner Change0.82%
Market Cap402.40M
Revenue(TTM)20.00K
Net Income(TTM)-83.92M
Analysts78.57
Price Target18.81 (387.31%)
Short Float %22.35%
Short Ratio7.28
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.69%
Min EPS beat(2)17.24%
Max EPS beat(2)26.14%
EPS beat(4)4
Avg EPS beat(4)18.17%
Min EPS beat(4)0.21%
Max EPS beat(4)29.11%
EPS beat(8)7
Avg EPS beat(8)14.31%
EPS beat(12)11
Avg EPS beat(12)15.65%
EPS beat(16)15
Avg EPS beat(16)15.29%
Revenue beat(2)2
Avg Revenue beat(2)296.04%
Min Revenue beat(2)296.04%
Max Revenue beat(2)296.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.6%
PT rev (3m)0%
EPS NQ rev (1m)82.86%
EPS NQ rev (3m)86.46%
EPS NY rev (1m)11.66%
EPS NY rev (3m)12.05%
Revenue NQ rev (1m)12.7%
Revenue NQ rev (3m)12.7%
Revenue NY rev (1m)88.81%
Revenue NY rev (3m)91.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20120.25
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB 2.17
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-1.24
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS1.78
TBVpS1.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.41%
ROE -45.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.39%
ROA(5y)-43.11%
ROE(3y)-56.08%
ROE(5y)-47.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.18
Quick Ratio 17.18
Altman-Z 3.12
F-Score3
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
EPS Next Y26.03%
EPS Next 2Y3.59%
EPS Next 3Y5.36%
EPS Next 5Y38.08%
Revenue 1Y (TTM)-61.54%
Revenue growth 3Y-83.45%
Revenue growth 5Y-67.82%
Sales Q2Q%0%
Revenue Next Year112.6%
Revenue Next 2Y0%
Revenue Next 3Y1667.5%
Revenue Next 5Y889.71%
EBIT growth 1Y9.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.22%
EBIT Next 3Y-13.84%
EBIT Next 5Y14.09%
FCF growth 1Y13.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.37%
OCF growth 3YN/A
OCF growth 5YN/A

ALTIMMUNE INC / ALT FAQ

What is the ChartMill fundamental rating of ALTIMMUNE INC (ALT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALT.


Can you provide the valuation status for ALTIMMUNE INC?

ChartMill assigns a valuation rating of 0 / 10 to ALTIMMUNE INC (ALT). This can be considered as Overvalued.


Can you provide the profitability details for ALTIMMUNE INC?

ALTIMMUNE INC (ALT) has a profitability rating of 1 / 10.


Can you provide the financial health for ALT stock?

The financial health rating of ALTIMMUNE INC (ALT) is 5 / 10.


What is the earnings growth outlook for ALTIMMUNE INC?

The Earnings per Share (EPS) of ALTIMMUNE INC (ALT) is expected to grow by 26.03% in the next year.